Eye & Ear - Medicare Optometrist in Boynton Beach, FL

Eye & Ear is a medicare enrolled "Optometrist" provider in Boynton Beach, Florida. Their current practice location is 514 E Woolbright Rd, Boynton Beach, Florida. You can reach out to their office (for appointments etc.) via phone at (561) 734-8975.

Eye & Ear is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Eye & Ear is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1013048479.

Contact Information

Eye & Ear
514 E Woolbright Rd,
Boynton Beach, FL 33435-6033
(561) 734-8975
(561) 734-4780



Healthcare Provider's Profile

Full NameEye & Ear
TypeFacility
SpecialityOptometrist
Location514 E Woolbright Rd, Boynton Beach, Florida
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1013048479
  • Provider Enumeration Date: 03/08/2007
  • Last Update Date: 03/31/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 0143432997
  • Enrollment ID: O20110210001057

Medical Identifiers

Medical identifiers for Eye & Ear such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013048479NPI-NPPES
620462700MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Eye & Ear acts as a billing entity for following providers:
Provider NamePamela R Reekers
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588789572
PECOS PAC ID: 9335169317
Enrollment ID: I20051207000046

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Provider NameBarry A Frankel
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1215961891
PECOS PAC ID: 6204978687
Enrollment ID: I20100122000571

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Provider NameRichard J Cohen
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1013932193
PECOS PAC ID: 3173758778
Enrollment ID: I20131107001403

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Provider NameAshley Ritchie
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1801236252
PECOS PAC ID: 9537382619
Enrollment ID: I20151209003030

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Provider NameAmber Lindahl
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1215551759
PECOS PAC ID: 5496160673
Enrollment ID: I20210222000434

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Provider NameNicholas Paul Viglucci
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306425772
PECOS PAC ID: 3173999158
Enrollment ID: I20221017000294

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eye & Ear is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eye & Ear
514 E Woolbright Rd,
Boynton Beach, FL 33435-6033

Ph: (561) 734-8975
Eye & Ear
514 E Woolbright Rd,
Boynton Beach, FL 33435-6033

Ph: (561) 734-8975

News Archive

Lung Cancer Alliance condoles the death of Edward Kennedy

Laurie Fenton-Ambrose, President and CEO of Lung Cancer Alliance extended condolences to the family of Senator Edward Kennedy who died of brain cancer late last night.

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

Yale-led study provides roadmap to discover new treatment for idiopathic pulmonary fibrosis

A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.

Universal access to malaria drugs, prevention by 2013 will lead to eradication, Nigerian Government says

The Nigerian government believes that by 2013 malaria will cease to be a major public health problem in the country because families will have universal access to prevention and treatment, which will ultimately lead to malaria eradication in Nigeria, according to a document prepared by the National Malaria Control Program of the Federal Ministry of Health in Abuja, Nigeria, Xinhua reports.

Retrovirox receives another NIH grant for novel inhibitors of HIV entry

RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.

Read more News

› Verified 4 days ago


Optometrist in Boynton Beach, FL

Dr. Richard J Cohen, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 514 E Woolbright Rd, Boynton Beach, FL 33435
Phone: 561-734-2972    Fax: 561-734-4780
Heg Business Management Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 6641 W Boynton Beach Blvd, Boynton Beach, FL 33437
Phone: 561-738-0111    Fax: 561-375-9359
Dr. Claudia V Soto, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3520 S Seacrest Blvd, Boynton Beach, FL 33435
Phone: 561-414-5704    
Stan S Choi, PA
Optometrist
Medicare: Medicare Enrolled
Practice Location: 650 N Congress Ave, Boynton Beach, FL 33426
Phone: 917-561-9791    
Dr Freed & Associates Pa
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7410 W Boynton Beach Blvd Ste A6, Boynton Beach, FL 33437
Phone: 561-734-7779    
Rebecca Claire Hill-moore, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2244 N Congress Ave, Boynton Beach, FL 33426
Phone: 561-739-0111    Fax: 561-735-9359

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.